Ranjan et al. raised concern for VLCDs in people with T1D in a study that demonstrated that one week of an isocaloric VLCD, defined as ≤50 g per day, reduced the treatment effect of glucagon given to treat mild hypoglycaemia [35]. The gene discussed is GCG; the disease is type 1 diabetes mellitus.